Hello friends, and welcome to episode 842 of the Juice Box podcast.

In March of 2021, on episode 452, I had an enlightening conversation with Francisco

Leone, who's a doctor, a PhD, and the CSO and co-founder of Prevention Bile.

At that time, we were talking about the deplisimop trial.

That trial must have gone okay because the FDA approved the drug, which is now called TZield,

and that brings us to today's episode with Lenny Ramos.

Lenny is the Chief Medical Officer of Prevention Bile, and she's here today to talk about TZield.

You're going to love this conversation, I promise.

While you're listening, please remember that nothing you'll hear on the Juice Box podcast

should be considered advice, medical, or otherwise, always consult a physician before making

any changes to your medical plan or becoming bold with insulin.

If you are inspired to help with type 1 diabetes research today, you can do so by helping

T1D Exchange.

Go to t1dexchange.org, forward slash Juice Box, join the registry, and fill out their

survey.

There is a lot to be excited about in this episode, so sit back, relax, and settle in.

Get those earbuds in nice and tight.

Are you doing the dishes?

Are you driving?

What are you doing right now?

If you have questions about insurance coverage for TZield, there'll be a statement at the

end.

...